<SEC-DOCUMENT>0001398344-25-017639.txt : 20250904
<SEC-HEADER>0001398344-25-017639.hdr.sgml : 20250904
<ACCEPTANCE-DATETIME>20250904192108
ACCESSION NUMBER:		0001398344-25-017639
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250904
DATE AS OF CHANGE:		20250904

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-83670
		FILM NUMBER:		251294691

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			POPLAR POINT CAPITAL MANAGEMENT LLC
		CENTRAL INDEX KEY:			0001588273
		ORGANIZATION NAME:           	
		EIN:				460530967
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		330 PRIMROSE ROAD, SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
		BUSINESS PHONE:		650-239-9049

	MAIL ADDRESS:	
		STREET 1:		330 PRIMROSE ROAD, SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: POPLAR POINT CAPITAL MANAGEMENT LLC -->
          <cik>0001588273</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <dateOfEvent>09/03/2025</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001389545</issuerCIK>
        <issuerCUSIP>66987P409</issuerCUSIP>
        <issuerName>Novabay Pharmaceuticals, Inc.</issuerName>
        <address>
          <com:street1>2000 Powell Street</com:street1>
          <com:street2>Suite 1150</com:street2>
          <com:city>Emeryville</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94608</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Jad Fakhry</personName>
          <personPhoneNum>650-239-9049</personPhoneNum>
          <personAddress>
            <com:street1>330 Primrose Road</com:street1>
            <com:street2>Suite 400</com:street2>
            <com:city>Burlingame</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94010</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588273</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital Management LLC</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588289</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital Partners LP</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588288</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital GP LLC</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588217</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Jad Fakhry</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.52</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.01 per share</securityTitle>
        <issuerName>Novabay Pharmaceuticals, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>2000 Powell Street</com:street1>
          <com:street2>Suite 1150</com:street2>
          <com:city>Emeryville</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94608</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>The securities to which this statement on Schedule 13D (this "Statement") relates are the shares with par value of $0.01 for NovaBay Pharmaceuticals, LLC.  The address of the principal executive office of the Issuer is 2000 Powell Street, Suite 1150, Emeryville, CA, Emeryville.</commentText>
      </item1>
      <item2>
        <filingPersonName>(i) Poplar Point Capital Management LLC ("PPCM"), is a Delaware limited liability company;

(ii) Poplar Point Capital Partners LP ("PPCP"), is a Delaware limited partnership;

(iii) Poplar Point Capital GP LLC ("PPCGP"), is a Delaware limited liability company;

(iv) Jad Fakhry ("Mr. Fakhry"), a United States citizen (collectively with PPCM, PPCP and PPCGP, the "Reporting Persons").

PPCM is the investment manager for PPCP.  PPCGP is the general partner of PPCP.  Mr. Fakhry is the manager of, and owns a controlling interest in, PPCM and PPCGP.</filingPersonName>
        <principalBusinessAddress>The address of the principal business and principal office of each of the Reporting Persons is:

330 Primrose Road, Suite 400
Burlingame, CA 94010</principalBusinessAddress>
        <principalJob>The principal business of the Reporting Persons is investing securities.

The principal occupation of Mr. Fakhry is serving as the Manager of Poplar Point.</principalJob>
        <hasBeenConvicted>During the past five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the past five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>PPCM is a Delaware limited liability company.
PPCP is a Delaware limited partnership.
PPCGP is a Delaware limited liability company.
Mr. Fakhry is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <fundsSource>PPCM directly holds 1,020,300 shares of Common Stock.  Consideration for these assets came from working capital of PPCM.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The purpose of the acquisition of the Common Stock is for investment, and the acquisitions of the Common Stock were made in the ordinary course of business.  Given the Reporting Persons' ownership percentage of the Issuer, the Reporting Persons holding of the Common Stock may have the purpose or effect of control.

At this time, the Reporting Persons have no specific plan or proposal to acquire additional Common Stock or dispose of the Common Stock.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>(i) PPCM
1,020,300
17.52%

(ii) PPCP
1,020,300
17.52%

(iii) PPCGP
1,020,300
17.52%

(iv) Jad Fakhry
1,020,300
17.52%</percentageOfClassSecurities>
        <numberOfShares>(i) PPCM
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(ii) PPCP
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(iii) PPCGP
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(iv) Jad Fakhry
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300</numberOfShares>
        <transactionDesc>In the past 60 days, the following transactions were effected by the Reporting Persons, in normal course of business:
Not applicable.</transactionDesc>
        <listOfShareholders>No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Other than as described in this Statement, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or between the Reporting Persons and any other persons with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>JOINT FILING AGREEMENT The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned's ownership of securities of the Issuer named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated this 4th day of September, 2025

POPLAR POINT CAPITAL MANAGEMENT LLC
By: /s/ Jad Fakhry
Jad Fakhry, Manager

POPLAR POINT CAPITAL PARTNERS LP
By: Poplar Point Capital GP LLC its General Partner
By: /s/ Jad Fakhry
Jad Fakhry, Manager

POPLAR POINT CAPITAL GP LLC
By: /s/ Jad Fakhry
Jad Fakhry, Manager

/s/ Jad Fakhry
JAD FAKHRY, an individual</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital Management LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>09/04/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital Partners LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>09/04/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital GP LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>09/04/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Jad Fakhry</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry</title>
          <date>09/04/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>fp0095334-1_ex99a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 11pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">VOTING AGREEMENT</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 21.4pt">THIS
VOTING AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;) is being signed on August 19, 2025 (the &ldquo;<B>Signature Date</B>&rdquo;)
by and among (a) NovaBay Pharmaceuticals, Inc. a Delaware corporation whose Common Stock is listed for trading on the NYSE American
(the &ldquo;<B>Proxy</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;), (b) Mr. David Elliot Lazar, an individual
(&ldquo;<B>Lazar</B>&rdquo;), and (c) each of (i) Mr. Jad Fakhry, an individual, (ii) Poplar Point Capital Management LLC, a
Delaware limited liability company, (iii) Poplar Point Capital Partners LP, a Delaware limited partnership, and (iv) Poplar Point
Capital GP LLC, a Delaware limited liability company (each person or entity part of group &ldquo;(c)&rdquo; hereinafter referred to
as, a &ldquo;<B>Stockholder</B>&rdquo; and collectively: the &ldquo;<B>Stockholders</B>&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 21.4pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.45pt">WHEREAS, the
Company and Lazar are contemplating entering into a Securities Purchase Agreement (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;)
that will provide for the sale and issuance of, <I>inter alia,</I> shares of newly designated series&rsquo; of Company preferred stock
(&ldquo;<B>Preferred Stock</B>&rdquo;), which shares, among other rights, are expected to be convertible into shares of the Company&rsquo;s
common stock, par value $0.01 per share (&ldquo;<B>Common Stock</B>&rdquo;), subject to and in accordance with the terms of the Securities
Purchase Agreement once finalized, and in connection with that Securities Purchase Agreement, the Stockholders desire to provide the Proxy
with certain contractual rights as set forth below.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.45pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.45pt">WHEREAS, Jad
Fakhry hereby represents that he does not have any beneficial interest in capital stock of the Company and in any other shares or securities
of the Company and/or any of its subsidiaries issued or issuable in respect thereof on and after the Signature Date, other than (a) individually,
(b) through Poplar Point Capital Management LLC, a Delaware limited liability company, (c) through Poplar Point Capital Partners LP, a
Delaware limited partnership, and/or (iv) through Poplar Point Capital GP LLC, a Delaware limited liability company, in each case as disclosed
in the Schedule 13D filed with the Securities and Exchange Commission on June 4, 2025.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.45pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.45pt">NOW, THEREFORE,
in consideration of the recitals set forth hereinabove and the mutual covenants and agreements herein contained, and other good and valuable
consideration, the receipt and sufficiency of which are acknowledged hereby, each of the parties hereto, intending legally to be bound,
hereby agrees as follows:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>1. &nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT><U>Incorporation
of Recitals</U>.</B> The parties to this Agreement hereby agree and acknowledge that all of the Recitals set forth hereinabove are
true, complete and correct in every respect and hereby incorporate said Recitals into this Agreement by this reference.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT><U>Representations of each Stockholder</U></B>. Each Stockholder hereby represents and warrants to the Proxy and Lazar that he/it:
(a) has full power to enter into this Agreement and has not, prior to the Signature Date, executed and/or delivered any proxy or entered
into any other voting agreement or similar arrangement and (b) will not take any action inconsistent with the purposes and provisions
of this Agreement. Without limiting the above or anything otherwise in this Agreement, each Stockholder represents that neither it nor,
any of its representatives or affiliates has (i) entered into (and, except with the prior written consent of the Proxy, agrees that it
will not and will use reasonable efforts to ensure that its representatives and affiliates will not enter into) directly or indirectly,
any agreement, arrangement or understanding with any person or firm as a principal, co-investor or co-bidder with respect to a possible
transaction involving the Company or that would restrict the ability of any other person to provide debt, equity or other financing for
a possible transaction involving the Company or (ii) engaged in any discussions which might lead to any agreement, arrangement or understanding
with any such person or firm.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;<U>Escrow
of Agreement</U></FONT></B>. Upon execution of this Agreement, it shall be placed in escrow with counsel to Lazar, McMurdo Law Group,
until the complete execution and effectiveness of the Securities Purchase Agreement by the Company and Lazar, at which time this Agreement
shall be released from such escrow to the benefit of the Proxy (the &ldquo;<B>Proxy Effective Date</B>&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;</FONT><U>Scope
of Agreement</U>.</B> Upon and following the Proxy Effective Date, this Agreement pertains to the vote of the 1,020,300 shares of
Common Stock, representing the aggregate voting interest of the Stockholders taken as a whole as of the Signature Date (assuming the
exercise by or vesting in the Stockholders of all equity-linked securities held by them), as well as any additional shares of Common
Stock which may be acquired by the Stockholders until the expiration of this Agreement (the &ldquo;<B>Proxy Shares</B>&rdquo;) by
the Proxy with respect to any and all matters concerning</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt"><FONT STYLE="font-size: 11pt">1</FONT><P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">a stockholder vote in respect of the
Proxy Shares with respect to actions to be taken by the Company and recommended by the Board of Directors of the Company at its annual
meeting of stockholders, including, <I>inter alia</I>, pursuant to the Securities Purchase Agreement between the Company and Lazar, to
the following matters:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt"> (a)&nbsp;&nbsp; effecting a reverse stock split of the Common Stock;</P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT>amending the Amended and Restated Certificate of Incorporation of the Company to provide for an increase in the number of authorized
shares of Company preferred stock and Common Stock;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt"> (c) &nbsp;&nbsp;electing new members to the Company&rsquo;s Board of Directors as may be nominated by Lazar;</P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT>approving
the issuance and/or conversion of Preferred Stock of the Company into shares of Common Stock, including in excess of 19.99% of the issued
and outstanding shares of Common Stock in accordance with NYSE American rules;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">In
addition, upon and following the Proxy Effective Date, each Stockholder hereby agrees that, for a period of two (2) years from the
Proxy Effective Date, unless such shall have been specifically invited in advance in writing by Lazar, no Stockholder, nor any of
its representatives acting on its behalf, will in any manner, directly or indirectly: (i) effect or seek, offer or propose (whether
publicly or otherwise) to effect, or cause or participate in or in any way advise, assist or encourage any other person to effect or
seek, offer or propose (whether publicly or otherwise) to effect or participate in, (a) any acquisition of any securities (or
beneficial ownership thereof) or assets of the Company, or any rights to acquire any such securities (including derivative
securities representing the right to vote or economic benefit of any such securities) or assets; (b) any tender or exchange offer,
merger or other business combination involving the Company; (c) any recapitalization, restructuring, liquidation, dissolution or
other extraordinary transaction with respect to the Company; or (d) any &ldquo;solicitation&rdquo; of &ldquo;proxies&rdquo; (as such
terms are used in the proxy rules of the Securities and Exchange Commission) or consents to vote any voting securities of the
Company; (ii) form, join or in any way participate in a &ldquo;group&rdquo; (as defined under the 1934 Act) with respect to any
securities of the Company; (iii) otherwise act, alone or in concert with others, to seek to control or influence the management,
board of directors or policies of the Company; (iv) take any action which might force the Company to make a public announcement
regarding any of the types of matters set forth in (i) above; (v) enter into any discussions or arrangements with any third party
with respect to any of the foregoing; or (vi) request that the Company (or its directors, officers, employees or agents) amend or
waive any provision of this paragraph (including this clause (vi)).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">Notwithstanding
anything to the contrary contained in this paragraph (the &ldquo;<B>Standstill Provision</B>&rdquo;) a Stockholder shall be permitted
to: 1) make proposals to the Company&rsquo;s Board of Directors or special committee, the chairman of the Board of Directors and/or chief
executive officer of the Company on a confidential, nonpublic basis for either (A) a proposed transaction between the parties, so long
as Stockholder reasonably believes in good faith, based on the written advice of its outside counsel, that neither it nor the Company
nor the Proxy would reasonably be expected to be required by applicable law, regulation or stock exchange requirement to disclose publicly
any such proposal or (B) a waiver of this Section 4 and 2) dispose of Stockholders&rsquo; shares in the Company, whenever acquired on
the open market, provided Stockholders shall not dispose of any shares owned as of the Signature Date until after</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(i) they have voted their 1,020,300
shares of Common Stock at the applicable stockholders meeting to approve the Securities Purchase Agreement, referred to herein and (ii)
such approval of the Securities Purchase Agreement is passed (the &ldquo;<B>Approval</B>&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>5.
&nbsp;&nbsp;<U>Changes in Capital Stock</U></B>. In the event that subsequent to the Signature Date, any shares of capital stock or other
securities the Company are issued on, or in exchange for, any of the Proxy Shares by reason of any stock dividend, stock split, consolidation
of shares, reclassification, exchange, merger or consolidation or otherwise involving the Company, such shares of capital stock or other
securities shall be deemed to be Proxy Shares for purposes of this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>6.
&nbsp;&nbsp;&nbsp;<U>Voting of Proxy Shares</U>.</B> Each Stockholder agrees and covenants that at any meeting of the stockholders of
the Company and/or in connection with any corporate action by the stockholders of the Company from the Signature Date until the termination
of this Agreement, all of his/its respective shares of the Proxy Shares shall be voted by the Stockholder in favor of all proposals recommended
by the Board of Directors of the Company that are presented for stockholder approval as set forth in Section 4 above or otherwise. Each
Stockholder agrees to promptly vote their Proxy Shares within seven (7) days after the Company files a definitive proxy statement for
a meeting of its stockholders. To the extent that such shares are not voted, then the Stockholders grant the Company an irrevocable proxy,
as provided in Section 7, to vote all of the Proxy Shares in the manner and to the effect determined by said Proxy in his sole and absolute
discretion with respect to actions proposed to be taken by the Company. Accordingly, during the term of this Agreement, no Stockholder
shall vote or attempt to vote any of his/its respective shares of the Proxy Shares, or otherwise exercise or attempt to exercise any
voting or other approval rights of any of his/its respective shares of the Proxy Shares except as provided in this Section 6, and any
such prohibited exercise by any Stockholder of voting or approval rights shall be void and of no force and effect.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt">2<P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>7.
<U>Irrevocable Proxy</U></B>.</P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">(a)
&nbsp;&nbsp;In order to give effect to and in furtherance of the agreements and covenants set forth in this Agreement, each Stockholder hereby
irrevocably constitutes and appoints Proxy as proxy for such Stockholder, with full power of substitution, for and in the name and
on behalf of such Stockholder, to vote any and all of his/its respective shares of Proxy Shares with regard to any question, action,
resolution, election or other matter presented to the stockholders of the Company in favor of and/or approval with respect to
actions proposed to be taken by the Company. Proxy shall vote said Proxy Shares in such manner and to such effect as the Proxy may
determine in his sole and absolute discretion with respect to actions proposed to be taken. The proxy granted hereby shall remain in
effect for so long as and at all times that this Agreement shall remain in effect. The proxy granted hereby is irrevocable and is
coupled with an interest sufficient in law to support an irrevocable proxy.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">
&nbsp;&nbsp;The Proxy hereby accepts its appointment as proxy of each Stockholder, pursuant to Subsection 7(a) of this Agreement. Other than as
specifically set forth herein, the Proxy shall have no other rights with respect to the Proxy Shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">(c)
&nbsp;&nbsp;In no way shall the terms of this Agreement be interpreted in a way to cause a violation of Section 160(c) of the Delaware General
Corporate Law or to prohibit, limit or restrict Proxy from exercising any fiduciary duties as an officer and/or director to the
Company at and from such time as the Proxy may be such.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">(d)
&nbsp;&nbsp;The voting of Proxy Shares pursuant to this Agreement may be effected in person, by proxy, by written consent or in any other manner
permitted by applicable law. For the avoidance of doubt, voting of the Proxy Shares pursuant to the Agreement need not make explicit
reference to the terms of this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt"><B>8.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;</FONT><U>Limitation
of Proxy&rsquo;s Liability</U>.</B> Proxy shall not incur any liability or responsibility by reason of any error of judgment,
mistake of law or other mistake, or for any act or omission of any agent or attorney, or for any misconstruction of this Agreement,
or for any action of any kind taken or omitted hereunder or believed by him to be in accordance with the provisions and intents
hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt"><B>9.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; &nbsp;&nbsp;</FONT><U>Consideration</U>. </B>In
exchange for the Irrevocable Proxy and the transfer of the voting rights of the Stockholders, Lazar and the Company shall use all
commercially reasonable efforts to 1) execute the Securities Purchase Agreement and undertake the actions contemplated therein,
including the investment by Lazar in the Company and 2) cause a special dividend per share at $0.80 (eighty cents per share), or
more, to be paid at the first available opportunity but no later than September 30, 2025, following the execution of the Securities
Purchase Agreement, to all common stockholders prior to the effect of any stock split, share consolidation or any other
recapitalization or act that would materially affect the number of shares outstanding. For the sake of clarity, the current common
shares outstanding of the Company equals 5,823,497 as of August 12, 2025, so the total special dividend to be paid to shareholders
shall be $0.80 multiplied by 5,823,497 equaling $4,658,797.60 before any fees or expenses related to processing the special
dividend.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt"><B>10.
&nbsp;&nbsp;<U>Term.</U></B></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 45.1pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;</FONT>This
Agreement shall commence on the Signature Date and continue for a period of two (2) years from the Proxy Effective Date, unless
terminated by Proxy, in Proxy&rsquo;s sole discretion.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt">3<P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.1pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT>The
Company and each Stockholder confirms hereby that he/it understands and acknowledges that this Agreement will continue for a period of
two (2) years from the Proxy Effective Date as set forth above, unless terminated by Proxy, in Proxy&rsquo;s sole discretion, and that
the preceding part of this Section 11(b) reflects his/its intention.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>11.
&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Successor Proxy</U></FONT></B>. In the event that the Proxy is
unable or unwilling to serve as the Proxy, a successor proxy (who will become the Proxy under this Agreement, if appointed in accordance
with this Section 11) may be appointed by the Proxy at its discretion, or if the Proxy is unable to make such appointment by the consent
of the successors to the Company&rsquo;s individual shares of capital stock that hold a majority interest in such shares. A successor
proxy shall be vested with all the rights, powers and authority as if originally named in this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt"><B>12.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;<U>Legend;
Subsequent Holders of Proxy Shares</U></FONT></B>. Each Stockholder hereby acknowledges and agrees that commencing on the Signature Date
all certificates for the shares of Proxy Shares may, but need not, be imprinted by the Company with notice of this Agreement and the
irrevocable proxy set forth herein. Each Stockholder agrees not to transfer any interest in his/its respective Proxy Shares, unless the
transferee executes and delivers a joinder and adoption agreement pursuant to which transferee or assignee of Proxy Shares shall continue
to be subject to the terms hereof and, as a condition precedent to any such transfer(s) (and the Company&rsquo;s recognizing such transfer(s)),
each such transferee or assignee shall agree in writing to be subject to each of the terms of this Agreement by executing and delivering
such joinder and adoption agreement to the satisfaction of the Proxy. Upon the execution and delivery of by any transferee joinder and
adoption agreement, such transferee shall be deemed to be a party hereto as if such transferee were the transferor and such transferee&rsquo;s
signature appeared on the signature pages of this Agreement and shall be deemed to be a Stockholder. A Stockholder shall not make, and
the Company shall not permit, the transfer of Proxy Shares on its books or issue a new certificate representing any such Proxy Shares
unless and until such transferee (or group) shall have complied with the terms of this Section 11.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>13.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;</FONT><U>Governing
Law; Jurisdiction and Venue</U>.</B> This Agreement shall be governed by and construed in accordance with the laws of the State of
Delaware, without regard to rules regarding choice of law. <B>EACH PARTY HERETO AGREES TO SUBMIT TO THE PERSONAL JURISDICTION AND
VENUE OF THE STATE AND/OR FEDERAL COURTS LOCATED IN WILMINGTON, DELAWARE FOR RESOLUTION OF ALL DISPUTES ARISING OUT OF, IN
CONNECTION WITH, OR BY REASON OF THE INTERPRETATION, CONSTRUCTION, AND ENFORCEMENT OF THIS AGREEMENT AND/OR ANY ADOPTION AGREEMENT,
AND HEREBY WAIVES THE CLAIM OR DEFENSE THEREIN THAT SUCH COURTS CONSTITUTE AN INCONVENIENT FORUM.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>14.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;</FONT><U>Benefits; Binding Effect</U>.</B> This Agreement shall be for the benefit of and binding upon the parties hereto and their respective
heirs, personal representatives, legal representatives, successors, assigns and transferees.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>15.
<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT><U>Counterparts</U>.</B> This Agreement may be executed in
several counterparts, and all so executed shall constitute one Agreement, binding on all the parties hereto, notwithstanding that all
the parties are not signatories to the original or same counterpart.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>16.
<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT><U>Amendment or Modification</U>.</B> This Agreement may
be altered, modified or amended only by the unanimous consent, in writing, of the parties hereto, either now or hereafter. Any such modification
must be signed by each party to this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt"><B>17.
<U></U>&nbsp;&nbsp;<U>Titles and Subtitles</U></B>. The titles and subtitles used in this Agreement are used for convenience only and
are not to be considered in construing or interpreting this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt"><B>18.&nbsp;&nbsp;
<U>Notices</U></B>. All notices and other communications given or made pursuant to this Agreement shall be c/o NovaBay Pharmaceuticals.
Inc., 2000 Powell Street, Suite 1150, Emeryville, California 94608 in writing and shall be deemed effectively given upon the earlier
of actual receipt or: (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail during normal business
hours of the recipient, and if not sent during normal business hours, then on the recipient&rsquo;s next business day, (c) five (5) days
after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) business day after
the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with
written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on <U>Schedule
A</U> hereto, or to such email address or address as subsequently modified by written notice given in accordance with this Section 18.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt">4<P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt"><B>19.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;</FONT><U>Delays
or Omissions</U></B>. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon
any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or
non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in
any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any
other breach or default previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the
part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or
conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing.
All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt"><B>20.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;</FONT><U>Further
Assurances</U></B>. At any time or from time to time after the date hereof, the parties agree to cooperate with each other, and at
the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as
the other party may reasonably request in order to evidence or effectuate the consummation of the transactions contemplated hereby
and to otherwise carry out the intent of the parties hereunder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 48.95pt"><B>21.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;</FONT><U>Specific
Enforcement</U></B>. The Stockholders acknowledges and agrees that irreparable harm will result in the event any of the provisions
of this Agreement are not performed by the Stockholders in accordance with their specific terms or are otherwise breached.
Accordingly, it is agreed that the Company shall be entitled to an injunction to prevent breaches of this Agreement, and to specific
enforcement of this Agreement and its terms and provisions in any action instituted in any court of the United States or any state
having subject matter jurisdiction, as further provided in Section 23.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>22. &nbsp;&nbsp;<U>Entire
Agreement</U>.</B> This Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter
hereof and supersedes all prior agreements, understandings and arrangements, both oral and written, among the parties hereto with
respect to such subject matter.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 44.95pt"><B>23. &nbsp;&nbsp;<U>Enforceability</U></B>.
The parties expressly agree that this Agreement shall be specifically enforceable in any court of competent jurisdiction in the
United States in accordance with its terms against each of the parties hereto. If any provision of this Agreement shall be declared
void or unenforceable by any court or administrative board of competent jurisdiction, such provision shall be deemed to have been
severed from the remainder of this Agreement and this Agreement shall continue in all respects to be valid and enforceable and shall
be construed so as to best give effect to the intention of the voided or unenforceable term or provision.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt">5<P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #2F2F2F">IN <B>WITNESS WHEREOF,</B>
the parties have executed this Voting Agreement as of the Signature Date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 35%">NOVABAY PHARMACEUTICALS, INC.</TD>
  <TD STYLE="width: 5%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Justin Hall</TD>
  <TD STYLE="width: 5%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>Justin Hall, CEO</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">JAD FAKHRY (in his individual capacity)</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">POPLAR POINT CAPITAL MANAGEMENT LLC</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry, Manager</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%"><P>POPLAR POINT CAPITAL PARTNERS LP</P></TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD>Poplar Point Capital GP LLC, its General Partner</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry, Manager</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">POPLAR POINT CAPITAL GP LLC</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry, Manager</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">DAVID ELLIOT LAZAR</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"></TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%"></TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>David Elliot Lazar</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="color: #2F2F2F"><I>[Signatur</I></FONT><I><FONT STYLE="color: #4F4F4F">e</FONT>
<FONT STYLE="color: #2F2F2F">Pa</FONT><FONT STYLE="color: #4F4F4F">g</FONT><FONT STYLE="color: #2F2F2F">e to Voting Agreement}</FONT></I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt">6<P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="text-align: right; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B><I>&nbsp;</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>IN WITNESS WHEREOF</B>, the parties have executed this Voting
Agreement as of the Signature Date.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 35%">NOVABAY PHARMACEUTICALS, INC.</TD>
  <TD STYLE="width: 5%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%"></TD>
  <TD STYLE="width: 5%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>Justin Hall, CEO</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">JAD FAKHRY (in his individual capacity)</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Jad Fakhry</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">POPLAR POINT CAPITAL MANAGEMENT LLC</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Jad Fakhry</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry, Manager</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%"><P>POPLAR POINT CAPITAL PARTNERS LP</P></TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD>Poplar Point Capital GP LLC, its General Partner</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Jad Fakhry</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry, Manager</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">POPLAR POINT CAPITAL GP LLC</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%; vertical-align: bottom">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ Jad Fakhry</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>Jad Fakhry, Manager</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 50%"></TD>
    <TD STYLE="text-align: left; width: 35%">DAVID ELLIOT LAZAR</TD>
    <TD STYLE="text-align: center; width: 15%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"></TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 30%">/s/ David Elliot Lazar</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>David Elliot Lazar</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt">7<P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>Execution Version</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Schedule A</U></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 11pt"><B>Company/Proxy:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 11pt">NovaBay Pharmaceuticals, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Address: 2000 Powell Street, Suite 1150,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Emeryville, California 94608</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Attention: Justin Hall</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>E-mail: jhall@novabay.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>With a copy, which shall not constitute notice, shall also be sent to abby.brown@squirepb.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Stockholders:</B></TD>
    <TD>Poplar Point Capital Management LLC </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Poplar Point Capital Partners LP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Poplar Point Capital GP LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Mr. Jad Fakhry</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Address: 330 Primrose Road, Suite 400</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Burlingame, CA 94010 Attention: Mr. Jad Fakhry</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>E-mail: jad@poplarpointcapital.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>With a copy, which shall not constitute notice, shall also be sent to Ben Fackler Ben.Fackler@arnoldporter.com and Daniel Fligsten dan@fligstenlawgroup.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Lazar:</B></TD>
    <TD>Mr. David Elliot Lazar Address:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>30B, Tower 200 The Towers,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>Winston Churchill, San Francisco, Paitilla, </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Panama City, Panama. 07196</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>E-mail: david@activistinvestingllc.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>With a copy, which shall not constitute notice, shall also be sent to: </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Mr. Avraham Ben-Tzvi, Attorney</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>Address:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>28 General Pierre Koenig St.,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>3rd Floor &ndash; Asif Business Center, Jerusalem 9346936, Israel</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>Email: abz@abz-law.com</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt">8<P STYLE="margin: 0pt; font: 9pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
